- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: lenalidomide (Revlimid)
Total 1146 results
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Netherlands, Belgium, Korea, Republic of, United Kingdom, Sweden, Denmark, Italy, Japan, Germany, France, Spain, Australia, Israel, Poland, Greece
-
Janssen Research & Development, LLCActive, not recruiting
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLymphoma, Mantle-CellTaiwan, Thailand, Malaysia, India, Puerto Rico, Spain, Turkey, Czechia, Brazil, Greece, Poland, Sweden, Romania
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, Germany, Netherlands, Israel, Spain, Saudi Arabia, France
-
Seagen Inc.Active, not recruitingDiffuse Large B-cell LymphomaUnited States, France, Australia, Czechia, Italy, Spain, Canada, Belgium, Korea, Republic of, United Kingdom, Poland, Denmark, Germany, Netherlands, Switzerland, Taiwan
-
Fondazione Italiana Linfomi - ETSActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingPrimary Effusion Lymphoma | B-Cell NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
GenmabAbbVieActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell LymphomaJapan
-
GenmabAbbVieActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingSmoldering Plasma Cell MyelomaUnited States
-
Teva takedaActive, not recruitingMultiple MyelomaUnited States, Spain, Belgium, Israel
-
Universitätsklinikum Hamburg-EppendorfActive, not recruiting
-
AmgenActive, not recruitingRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany, France, Italy, Denmark, Greece, Estonia
-
Hoffmann-La RocheActive, not recruitingFollicular LymphomaUnited Kingdom, United States, China, France, Spain
-
Janssen Research & Development, LLCCompletedMultiple MyelomaIsrael, Czechia, United States, Germany, Spain, United Kingdom, France, Japan, Brazil
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, France, United Kingdom, Belgium, Germany, Israel, Australia, Sweden, Canada, Netherlands, Austria, Ireland, Denmark
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Hartford HospitalCompleted
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
National Cancer Institute (NCI)CompletedUrethral Neoplasms | Urethral Cancer | Neoplasms, Urethral | Cancer of the UrethraUnited States
-
Poitiers University HospitalSanofi; Intergroupe Francophone du MyelomeActive, not recruitingMultiple Myeloma | Myeloma | Myeloma MultipleFrance
-
University of LeedsCelgene; Janssen, LP; Myeloma UKActive, not recruiting
-
MorphoSys AGActive, not recruitingDiffuse Large B Cell LymphomaSpain, Czechia, Korea, Republic of, Israel, Poland, Italy, Austria, France, United States
-
Fudan UniversityCompletedDouble Expressor LymphomaChina
-
Xencor, Inc.TerminatedDiffuse Large-cell B-cell LymphomaSpain, United States, France
-
TakedaActive, not recruiting
-
Wake Forest University Health SciencesCelgene; Amgen; Janssen, LPActive, not recruitingMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.TerminatedRelapsed or Refractory Systemic Light Chain AmyloidosisUnited States, Canada, Spain, Israel, France, Australia, Denmark, Germany, Korea, Republic of, Greece, Netherlands, Brazil, Czechia, Italy, United Kingdom
-
Acerta Pharma BVAstraZenecaActive, not recruitingNon Hodgkin LymphomaUnited States, Canada, Italy
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCActive, not recruiting
-
Wake Forest University Health SciencesGlaxoSmithKline; AmgenActive, not recruitingMultiple MyelomaUnited States
-
TJ Biopharma Co., Ltd.Active, not recruitingRefractory Multiple Myeloma | Multiple Myeloma in RelapseChina, Taiwan
-
Qianfoshan HospitalCompletedLymphoma | Myelodysplastic Syndromes | Multiple MyelomaChina
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
NuCana plcCompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States, France, United Kingdom
-
BeiGeneCompletedRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenCompletedMultiple MyelomaAustria, Germany
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Spain
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.Active, not recruitingPrimary Central Nervous System Lymphoma (PCNSL) | Secondary Central Nervous System Lymphoma (SCNSL)United States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States
-
University Hospital, LilleActive, not recruiting
-
University of NebraskaTerminatedPlasma Cell MyelomaUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
Incyte CorporationActive, not recruitingFollicular Lymphoma | Marginal Zone LymphomaFinland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
MorphoSys AGActive, not recruitingDiffuse Large B-cell LymphomaGermany, France, Hungary, Italy, Spain, United States, Austria, Czechia, Australia, Israel, Korea, Republic of, Turkey, Taiwan, Argentina, Canada, Colombia, Ireland, Japan, Malaysia, New Zealand, Philippines, Poland, Romania, Russian... and more